Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy - Concepedia

Concepedia

Publication | Closed Access

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

2.2K

Citations

20

References

2000

Year

Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson, Richard J. Gralla, Mark Allen O’Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald L. Burkes,

Journal of Clinical Oncology

Abstract

Treatment with docetaxel is associated with significant prolongation of survival, and at a dose of 75 mg/m(2), the benefits of docetaxel therapy outweigh the risks.

References

	Year	Citations

Page 1